Elevated SLC6A6 expression drives tumorigenesis and affects clinical outcomes in gastric cancer | |
Wang Dazhi; Du Jing; Ren Chunling; Zhou Mi; Xia Zhixuan | |
刊名 | BIOMARKERS IN MEDICINE |
2019 | |
卷号 | 13期号:2页码:95-104 |
关键词 | cancer biomarkers gastric carcinoma poor prognosis solute carrier family 6 member 6 |
DOI | 10.2217/bmm-2018-0256 |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4530168 |
专题 | 山东大学 |
作者单位 | 1.Qingdao Municipal Hosp, Qingdao 266071, Peoples R China. 2.Shandong Univ, Cheeloo Coll Med, Pharm Dept, J |
推荐引用方式 GB/T 7714 | Wang Dazhi,Du Jing,Ren Chunling,et al. Elevated SLC6A6 expression drives tumorigenesis and affects clinical outcomes in gastric cancer[J]. BIOMARKERS IN MEDICINE,2019,13(2):95-104. |
APA | Wang Dazhi,Du Jing,Ren Chunling,Zhou Mi,&Xia Zhixuan.(2019).Elevated SLC6A6 expression drives tumorigenesis and affects clinical outcomes in gastric cancer.BIOMARKERS IN MEDICINE,13(2),95-104. |
MLA | Wang Dazhi,et al."Elevated SLC6A6 expression drives tumorigenesis and affects clinical outcomes in gastric cancer".BIOMARKERS IN MEDICINE 13.2(2019):95-104. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论